The National Institutes of Health (NIH) is sponsoring a Consensus Development Conference on Adjuvant Therapy for Breast Cancer, to be held in Bethesda, Maryland, on November 1-3, 2000.
The conference will focus on new data on chemotherapy, hormonal therapy, and other aspects of treatment that have emerged over the past decade since the last consensus conference, and will culminate in the formulation of recommendations for clinical practice.
During the conference, a panel of experts (from outside of the NIH) will hear presentations from leading researchers and then consider questions on specific topics, such as the selection of chemotherapy, radiation therapy, and hormonal therapy. The agenda will also include the clinical use of prognostic markers and quality-of-life issues. Both node-negative and node-positive breast cancers will be discussed.
Health professionals, researchers, patient advocates, and other members of the public may register to attend the by sending an e-mail to breastcancer@prospectassoc.com or by going to the NIH web site for consensus conferences found at http://odp.od.nih.gov/consensus. Additional information is available by calling (301) 592-3320.
A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?
